Cart
sales@molnova.com
BSBM7
CAS No. 6968-11-2
BSBM7( —— )
Catalog No. M22384 CAS No. 6968-11-2
BSBM7 is an inhibitor of Aβ aggregation and neuronal toxicity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1G | 26 | In Stock |
|
Biological Information
-
Product NameBSBM7
-
NoteResearch use only, not for human use.
-
Brief DescriptionBSBM7 is an inhibitor of Aβ aggregation and neuronal toxicity.
-
DescriptionBSBM7 is an inhibitor of Aβ aggregation and neuronal toxicity.
-
In VitroAmino acids and amino acid derivatives have been commercially used as ergogenic supplements. They influence the secretion of anabolic hormones, supply of fuel during exercise, mental performance during stress related tasks and prevent exercise induced muscle damage. They are recognized to be beneficial as ergogenic dietary substances.
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetBeta Amyloid
-
RecptorAβ
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number6968-11-2
-
Formula Weight508.56
-
Molecular FormulaC22H24N2O8S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC(=O)[C@H](CSSC[C@H](NC(=O)OCc1ccccc1)C(O)=O)NC(=O)OCc1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Solanezumab
Solanezumab (LY 2062430) is a monoclonal antibody that binds preferentially to soluble amyloid and promotes its clearance from the brain.Solanezumab is used in the study of Alzheimer's disease.
-
Humantenmine
Humantenmine and koumine may inhibit several CYP450 enzyme activities.
-
MAO-B-IN-9
MAO-B-IN-9 is a monoamine oxidase B MAO-B inhibitor (IC50: 0.18 μM) that crosses the blood-brain barrier with potency, selectivity and time-dependence.
